James Chen, CMT is an expert trader, investment adviser, and global market strategist. Charlene Rhinehart is a CPA , CFE, chair of an Illinois CPA Society committee, and has a degree in accounting and ...

On Thursday, the Food and Drug Administration’s (FDA) committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies ...

The panel had previously voted to recommend four peptides under review on Thursday: BPC-157, KPV, MOTS-c and TB-500. This is the first time an FDA panel has voted to ease access to unapproved peptides ...

The Chanakya Principle Behind Every Rupee You Don't Spend Chanakya wrote in the Arthashastra that a man who cannot control ...

Despite a lack of evidence of clinical benefit and substantial safety and quality concerns, an FDA advisory committee ...

If the agency follows the committee’s advice, it will issue a rule that would allow the compounds to be sold for any condition.

When you have to go on a medication, your doctor will probably prescribe a premade one that's FDA-approved. But sometimes, they may want you to go on a compounded medicine that's specifically made for ...

This past June, the FDA sent out 25 warning letters to telehealth companies selling compounded semaglutide and ...

Six peptides received narrow advisory support for potential 503A Bulks List inclusion, an atypical outcome given FDA staff recommendations against all seven under review. Legal compounding remains ...

Leveraged ETFs amplify returns on an underlying asset. Adding options to the mix can further magnify them, but the risks rise ...